Press Releases

July 15, 2024
– Two New Independent Directors, Stuart Duty and Andrew Saik , Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C. , July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ®   Pharmaceuticals Inc. (Nasdaq: MIST) (“Milestone” or the “Company”), a
April 8, 2024
Data from this large safety-trial also published in The Journal of the American College of Cardiology MONTREAL and CHARLOTTE, N.C. , April 08, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of
Displaying 1 - 10 of 17
Print Page
RSS Feeds
Email Alerts
Investor Contact